Cisplatin Eligibility and Maintenance Therapy in Metastatic Urothelial Carcinoma

Opinion
Video

The expert panel discusses how treatment strategies change based on cisplatin eligibility and the role of maintenance therapy in metastatic urothelial carcinoma.

Related Videos
Robert Wang, MD, of Fox Chase Cancer Center
A panel of 4 experts on colorectal cancer
A panel of 4 experts on colorectal cancer
Alexander Kutikov, MD, FACS, of Fox Chase Cancer Center
Jaime R. Merchán, MD
Video 14 - "Toxicity Profiles for DTC Guidelines Therapies"
Video 13 - "Understanding the Impact of COSMIC-311 and Sequencing in DTC"
A panel of 5 experts on lung cancer
A panel of 5 experts on lung cancer